Universal Cells
Annie Chen is a highly experienced professional in the field of biotechnology, with a background in various research and assistant roles at prestigious organizations such as Universal Cells, STEMCELL Technologies, Amgen, and more. Annie holds a BSc Honours in Biotechnology from The University of British Columbia and a Diploma in Biotechnology from the British Columbia Institute of Technology. Annie's career has been focused on clinical gene editing and research in the life sciences sector.
Universal Cells
Universal Cells is a Seattle-based biotech developing, licensing and commercializing stem cell therapies that overcome immune rejection and can be used to create true off-the-shelf therapeutic products. Using the company's proprietary genome editing approach, the company engineers stem cells to prevent expression of polymorphic human leukocyteantigen (HLA) molecules, removing the cause of donor tissue rejection and creating Universal Donor Stem Cells that are compatible with every patient.